GLP-2 (TRZ)
GLP-2 (TRZ), also known as tirzepatide, is a synthetic peptide that acts on both GIP and GLP-1 receptors. Each batch undergoes independent, third-party HPLC testing to verify purity, with batch-specific Certificates of Analysis published for transparent review and direct verification with the testing laboratory.
For laboratory research use only.
Choose your vial strength below.
Technical Overview
Tirzepatide is a synthetic peptide and dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. These receptors are involved in cellular signaling pathways associated with glucose regulation and energy metabolism.
Supplied as a lyophilized powder, each batch undergoes independent, third-party HPLC testing to verify purity. Batch-specific Certificates of Analysis are available directly on the product page.
For laboratory research use only. Not for human or veterinary use.
